U.S. Autism Spectrum Disorder Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Therapy (Antipsychotic Drugs, SSRIs/Antidepressants, Stimulants, Sleep Medications, and Others), By Disease (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), By Age Group (Children and Adults), By Distribution Channel (Hospital Pharmacies, Drugs Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108931

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 8.7% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Drug Therapy Antipsychotic Drugs SSRIs/Antidepressants Stimulants Sleep Medications Others
	By Disease Autistic Disorder Asperger Syndrome Pervasive Developmental Disorder (PDD) Others
	By Age Group Children Adults
	By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies